Compile Data Set for Download or QSAR
Report error Found 131 Enz. Inhib. hit(s) with all data for entry = 12275
TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692449(US20240270732, Compound I-100)
Affinity DataIC50: 1.47nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692451(US20240270732, Compound I-102)
Affinity DataIC50: 1.88nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692354(US20240270732, Compound I-11)
Affinity DataIC50: 1.96nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692448(US20240270732, Compound I-99)
Affinity DataIC50: 2.39nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692450(US20240270732, Compound I-101)
Affinity DataIC50: 2.54nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692375(US20240270732, Compound I-31 | US20240270732, Comp...)
Affinity DataIC50: 2.62nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692355(US20240270732, Compound I-12)
Affinity DataIC50: 2.75nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692374(US20240270732, Compound I-29)
Affinity DataIC50: 2.88nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692375(US20240270732, Compound I-31 | US20240270732, Comp...)
Affinity DataIC50: 2.95nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692369(US20240270732, Compound I-32 | US20240270732, Comp...)
Affinity DataIC50: 3.08nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692472(US20240270732, Compound I-123)
Affinity DataIC50: 3.17nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692471(US20240270732, Compound I-122)
Affinity DataIC50: 3.18nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692353(US20240270732, Compound I-10)
Affinity DataIC50: 3.21nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692356(US20240270732, Compound I-13)
Affinity DataIC50: 3.22nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692348(US20240270732, Compound I-5)
Affinity DataIC50: 3.35nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692370(US20240270732, Compound I-25)
Affinity DataIC50: 3.39nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692378(US20240270732, Compound I-33)
Affinity DataIC50: 3.54nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692361(US20240270732, Compound I-17)
Affinity DataIC50: 3.56nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692371(US20240270732, Compound I-26)
Affinity DataIC50: 3.73nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM682029(US20240270732, Compound I-15 | US20240270732, Comp...)
Affinity DataIC50: 3.81nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692372(US20240270732, Compound I-27)
Affinity DataIC50: 4nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692366(US20240270732, Compound I-37 | US20240270732, Comp...)
Affinity DataIC50: 4.17nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692383(US20240270732, Compound I-38)
Affinity DataIC50: 4.18nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692458(US20240270732, Compound I-109)
Affinity DataIC50: 4.26nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692440(US20240270732, Compound I-91)
Affinity DataIC50: 4.36nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692375(US20240270732, Compound I-31 | US20240270732, Comp...)
Affinity DataIC50: 4.36nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM682028(US20240270732, Compound I-14 | US20240270732, Comp...)
Affinity DataIC50: 4.52nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692373(US20240270732, Compound I-28)
Affinity DataIC50: 4.59nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692367(US20240270732, Compound I-23)
Affinity DataIC50: 4.66nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692369(US20240270732, Compound I-32 | US20240270732, Comp...)
Affinity DataIC50: 4.68nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692379(US20240270732, Compound I-34)
Affinity DataIC50: 4.68nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692459(US20240270732, Compound I-110)
Affinity DataIC50: 4.73nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM682028(US20240270732, Compound I-14 | US20240270732, Comp...)
Affinity DataIC50: 4.79nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692473(US20240270732, Compound I-124)
Affinity DataIC50: 4.84nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692454(US20240270732, Compound I-105)
Affinity DataIC50: 4.85nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM682029(US20240270732, Compound I-15 | US20240270732, Comp...)
Affinity DataIC50: 4.88nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692470(US20240270732, Compound I-121)
Affinity DataIC50: 4.92nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692387(US20240270732, Compound I-42)
Affinity DataIC50: 5.03nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692360(US20240270732, Compound I-16)
Affinity DataIC50: 5.59nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692386(US20240270732, Compound I-41)
Affinity DataIC50: 5.59nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692442(US20240270732, Compound I-93)
Affinity DataIC50: 5.73nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692441(US20240270732, Compound I-92)
Affinity DataIC50: 5.89nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692366(US20240270732, Compound I-37 | US20240270732, Comp...)
Affinity DataIC50: 5.89nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692403(US20240270732, Compound I-58)
Affinity DataIC50: 6.16nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692443(US20240270732, Compound I-94)
Affinity DataIC50: 6.16nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692439(US20240270732, Compound I-90)
Affinity DataIC50: 6.29nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692436(US20240270732, Compound I-87)
Affinity DataIC50: 6.32nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692455(US20240270732, Compound I-106)
Affinity DataIC50: 6.53nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692437(US20240270732, Compound I-88)
Affinity DataIC50: 6.58nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Chengdu Biobel Biotechnology Co.

US Patent
LigandPNGBDBM692428(US20240270732, Compound I-82-1)
Affinity DataIC50: 6.60nMAssay Description:The compound of the present invention and the control compound were dissolved in the assay buffer (50 mM Hepes pH 7.5, 50 mM NaCl, 30 mM MgCl2, 1 mM ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/3/2024
Entry Details
US Patent

Displayed 1 to 50 (of 131 total ) | Next | Last >>
Jump to: